Your browser doesn't support javascript.
loading
Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
Lang, Jiayan; Zhao, Xiao; Wang, Xiuchao; Zhao, Ying; Li, Yiye; Zhao, Ruifang; Cheng, Keman; Li, Yao; Han, Xuexiang; Zheng, Xiaowei; Qin, Hao; Geranpayehvaghei, Marzieh; Shi, Jian; Anderson, Gregory J; Hao, Jihui; Ren, He; Nie, Guangjun.
Affiliation
  • Lang J; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Zhao X; Sino-Danish Center for Education and Research/Sino-Danish College of UCAS , Beijing 100190 , China.
  • Wang X; University of Chinese Academy of Sciences , Beijing 100049 , China.
  • Zhao Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Li Y; Center of Materials Science and Optoelectronics Engineering , University of Chinese Academy of Sciences , Beijing 100049 , China.
  • Zhao R; Department of Pancreatic Carcinoma , Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy , Tianjin 300060 , China.
  • Cheng K; Department of Pancreatic Carcinoma , Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy , Tianjin 300060 , China.
  • Li Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Han X; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Zheng X; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Qin H; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Geranpayehvaghei M; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Shi J; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Anderson GJ; University of Chinese Academy of Sciences , Beijing 100049 , China.
  • Hao J; Department of Pancreatic Carcinoma , Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy , Tianjin 300060 , China.
  • Ren H; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.
  • Nie G; University of Chinese Academy of Sciences , Beijing 100049 , China.
ACS Nano ; 13(2): 2176-2189, 2019 02 26.
Article in En | MEDLINE | ID: mdl-30676731
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Iron Chelating Agents / Drug Delivery Systems / Deferoxamine / Hypoxia-Inducible Factor 1, alpha Subunit / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: ACS Nano Year: 2019 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Iron Chelating Agents / Drug Delivery Systems / Deferoxamine / Hypoxia-Inducible Factor 1, alpha Subunit / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: ACS Nano Year: 2019 Document type: Article Affiliation country: China Country of publication: United States